Status™ COVID-19/Flu A&B Antigen Rapid Test

As of October 27, 2021 the StatusTM COVID-19/Flu A&B is now authorized for use with anterior nasal swab specimens as well as nasopharyngeal swab specimens. Read more about it here A Rapid Immunoassay for the Simultaneous Direct Detection and Differential Diagnosis of SARS-CoV-2, Influenza Type A and Type B Antigen from nasopharyngeal swab specimens FDA Emergency Use Authorization (EUA) Visually read in 15 minutes Flocked nasopharyngeal swab for superior specimen collection and patient comfort Sensitivity and Specificity COVID-19 - Sensitivity 93.9%, Specificity 100% Flu A - Sensitivity 91.4%, Specificity 95.7% Flu B - Sensitivity 87.6%, Specificity 95.9% CPT CODES:  COVID-19: 87811FLU A: 87804QWFLU B: 87804QW-59 Product AttachmentsExpiration Dating MemoStatus™ COVID-19/Flu Package InsertStatus™ COVID-19/Flu SDSStatus™ COVID-19/Flu CLSIStatus™ COVID-19/Flu Provider Fact SheetStatus™ COVID-19/Flu Patient Fact SheetStatus™ COVID-19/Flu Procedure CardStatus™ COVID-1